These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23886194)

  • 1. Steroid receptor coactivator-3 promotes bladder cancer through upregulation of CXCR4.
    Zhang Y; Wang JH; Liu B; Qu PB
    Asian Pac J Cancer Prev; 2013; 14(6):3847-50. PubMed ID: 23886194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.
    Shen HB; Gu ZQ; Jian K; Qi J
    Tumour Biol; 2013 Jun; 34(3):1839-45. PubMed ID: 23526079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.
    Zhao W; Chang C; Cui Y; Zhao X; Yang J; Shen L; Zhou J; Hou Z; Zhang Z; Ye C; Hasenmayer D; Perkins R; Huang X; Yao X; Yu L; Huang R; Zhang D; Guo H; Yan J
    J Biol Chem; 2014 Apr; 289(16):11219-11229. PubMed ID: 24584933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
    Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
    Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.
    Xu J; Wu RC; O'Malley BW
    Nat Rev Cancer; 2009 Sep; 9(9):615-30. PubMed ID: 19701241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.
    Geng C; He B; Xu L; Barbieri CE; Eedunuri VK; Chew SA; Zimmermann M; Bond R; Shou J; Li C; Blattner M; Lonard DM; Demichelis F; Coarfa C; Rubin MA; Zhou P; O'Malley BW; Mitsiades N
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6997-7002. PubMed ID: 23559371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis.
    Ma X; Xu L; Wang S; Cui B; Li X; Xu J; Ning G
    J Hepatol; 2011 Aug; 55(2):445-52. PubMed ID: 21184786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRC-3 has a role in cancer other than as a nuclear receptor coactivator.
    Ma G; Ren Y; Wang K; He J
    Int J Biol Sci; 2011; 7(5):664-72. PubMed ID: 21647249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.
    Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; O'Malley BW
    Mol Endocrinol; 2011 Dec; 25(12):2041-53. PubMed ID: 22053001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual role of TGFBR3 in bladder cancer.
    Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
    Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator.
    Labhart P; Karmakar S; Salicru EM; Egan BS; Alexiadis V; O'Malley BW; Smith CL
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1339-44. PubMed ID: 15677324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
    Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential recruitment of p160 coactivators by glucocorticoid receptor between Schwann cells and astrocytes.
    Grenier J; Trousson A; Chauchereau A; Cartaud J; Schumacher M; Massaad C
    Mol Endocrinol; 2006 Feb; 20(2):254-67. PubMed ID: 16179382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-interacting protein suppresses bladder carcinogenesis.
    Nishizawa K; Nishiyama H; Matsui Y; Kobayashi T; Saito R; Kotani H; Masutani H; Oishi S; Toda Y; Fujii N; Yodoi J; Ogawa O
    Carcinogenesis; 2011 Oct; 32(10):1459-66. PubMed ID: 21771725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRC-3 is required for prostate cancer cell proliferation and survival.
    Zhou HJ; Yan J; Luo W; Ayala G; Lin SH; Erdem H; Ittmann M; Tsai SY; Tsai MJ
    Cancer Res; 2005 Sep; 65(17):7976-83. PubMed ID: 16140970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iASPP is important for bladder cancer cell proliferation.
    Liu T; Li L; Yang W; Jia H; Xu M; Bi J; Li Z; Liu X; Li Z; Jing H; Kong C
    Oncol Res; 2011; 19(3-4):125-30. PubMed ID: 21473288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
    Shah YM; Rowan BG
    Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.
    Cavarretta IT; Mukopadhyay R; Lonard DM; Cowsert LM; Bennett CF; O'Malley BW; Smith CL
    Mol Endocrinol; 2002 Feb; 16(2):253-70. PubMed ID: 11818499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
    Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
    Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
    Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
    Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.